2020
DOI: 10.1101/2020.11.25.398636
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Intracellular localisation ofMycobacterium tuberculosisaffects antibiotic efficacy

Abstract: To be effective, chemotherapy against tuberculosis (TB) must kill the intracellular population of Mycobacterium tuberculosis (Mtb). However, how host cell environments affect antibiotic accumulation and efficacy remains elusive. Pyrazinamide (PZA) is a key antibiotic against TB, yet its behaviour is not fully understood. Here, by using correlative light, electron, and ion microscopy to image PZA at the subcellular level, we investigated how human macrophage environments affect PZA activity. We discovered that … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(12 citation statements)
references
References 56 publications
4
8
0
Order By: Relevance
“…The determination of PZA half maximal effective concentration (EC50) using a four-parameter logistic non-linear regression model showed that ConA co-treatment increased, by approximately 3.5 times, the amount of antibiotic required to efficiently inhibit 50% of Mtb growth in cellulo (49.5 ± 19.2 mg/L and 173.1 ± 35.2 mg/L, respectively) (Figure 4A-4B). These results agree with our previous observations showing that the use of v-ATPase inhibitors is able to counteract PZA/POA-mediated growth inhibition by impairing POA accumulation within the bacteria (Santucci et al, 2021). These experiments were also performed in another human macrophage model using iPSDM (Figure S6).…”
Section: Endolysosomal Acidification and Protonophore Activity Of Pza Contribute To Mtb Restriction In Human Macrophagessupporting
confidence: 91%
See 4 more Smart Citations
“…The determination of PZA half maximal effective concentration (EC50) using a four-parameter logistic non-linear regression model showed that ConA co-treatment increased, by approximately 3.5 times, the amount of antibiotic required to efficiently inhibit 50% of Mtb growth in cellulo (49.5 ± 19.2 mg/L and 173.1 ± 35.2 mg/L, respectively) (Figure 4A-4B). These results agree with our previous observations showing that the use of v-ATPase inhibitors is able to counteract PZA/POA-mediated growth inhibition by impairing POA accumulation within the bacteria (Santucci et al, 2021). These experiments were also performed in another human macrophage model using iPSDM (Figure S6).…”
Section: Endolysosomal Acidification and Protonophore Activity Of Pza Contribute To Mtb Restriction In Human Macrophagessupporting
confidence: 91%
“…Next, Mtb-associated LysoTracker intensity and Mtb intrabacterial pH were analysed by automated high-content microscopy (Figure S1). A quantitative analysis in IQRCTRL = 334.9 and medianConA = 241.6;IQRConA = 64.5,respectively) and Mtb-infected iPSDM (medianCTRL = 1964.2, IQRCTRL = 1006.0 andmedianConA = 929.3;IQRConA = 1009.4, respectively) showed that the median Mtb-associated LysoTracker intensity was reduced by approximately 2-fold upon ConA treatment (Figure 1A and Figure 1C), confirming that endolysosomal acidification was impaired (Santucci et al, 2021). On the other hand, a quantitative analysis of Mtb intrabacterial pH in control or ConA-treated conditions were similar in both infected MDM (Figure 1B) and infected iPSDM (Figure 1D) with absolute median differences that were almost null (ΔmedianpH-GFP = 0.035 and 0.016 respectively), suggesting that intracellular acidification does not impact Mtb intrabacterial pH in human macrophages.…”
Section: A Live Dual-imaging Approach To Monitor Organelle and Mtb Acidificationmentioning
confidence: 57%
See 3 more Smart Citations